Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 4/20 | 0.49 |
| ▸ | COMT | P21964 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30983035 | 0.76 | BCL2L1 (0.39) | TYRCOMTLMNAALDH1A1BCL2L1 | |
| SCHEMBL30982718 | 0.75 | LMNA (0.35) | TYRLMNAALDH1A1BCL2L1CA2 | |
| SCHEMBL621548 | 0.75 | KDM4E (0.39) | TYRLMNAALDH1A1BCL2L1 | |
| SCHEMBL30983065 | 0.74 | KDM4E (0.50) | TYRCOMTLMNAALDH1A1BCL2L1 | |
| SCHEMBL30983080 | 0.74 | ALDH1A1 (0.37) | TYRLMNAALDH1A1BCL2L1CA2 | |
| SCHEMBL30982956 | 0.74 | TYR (0.64) | TYRCOMT | |
| SCHEMBL30982651 | 0.74 | TYR (0.64) | TYRCOMT | |
| SCHEMBL30982383 | 0.74 | TYR (0.64) | TYRCOMT | |
| SCHEMBL30982770 | 0.73 | KDM4E (0.47) | COMTLMNAALDH1A1BCL2L1CA2 | |
| SCHEMBL30982493 | 0.73 | BCL2L1 (0.39) | TYRLMNAALDH1A1BCL2L1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606765-B2 | Multipurpose oxypyridinones and their functional use—1 | INFINEUM INTERNATIONAL LIMITED (US) | 2026-04-21 | — | — | US | disclosed |
| US-12606766-B2 | Multipurpose oxypyridinones and their functional use-4 | INFINEUM INTERNATIONAL LIMITED (US) | 2026-04-21 | — | — | US | disclosed |
| US-12503666-B2 | Multipurpose oxypyridinones and their functional use-2 | INFINEUM INTERNATIONAL LIMITED (US) | 2025-12-23 | — | — | US | disclosed |
| US-20240294840-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 | INFINEUM INTERNATIONAL LIMITED (US) | 2024-09-05 | — | — | US | disclosed |
| US-20240294842-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-4 | INFINEUM INTERNATIONAL LIMITED (US) | 2024-09-05 | — | — | US | disclosed |
| US-20240294841-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-3 | INFINEUM INTERNATIONAL LIMITED (US) | 2024-09-05 | — | — | US | disclosed |
| US-20240287405-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE - 1 | INFINEUM INTERNATIONAL LIMITED (US) | 2024-08-29 | — | — | US | disclosed |
| EP-4417673-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE | Infineum International Limited (GB) | 2024-08-21 | — | — | EP | disclosed |
| EP-4417674-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE | Infineum International Limited (GB) | 2024-08-21 | — | — | EP | disclosed |
| EP-4417672-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE | Infineum International Limited (GB) | 2024-08-21 | — | — | EP | disclosed |
| EP-4417675-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE | Infineum International Limited (GB) | 2024-08-21 | — | — | EP | disclosed |
| CN-118516151-A | Multipurpose oxypyridones and their functional use | 英菲诺姆国际有限公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-118516152-A | Multipurpose oxypyridones and their functional use | 英菲诺姆国际有限公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-118516154-A | Multipurpose oxypyridones and their functional use | 英菲诺姆国际有限公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-118516153-A | Multipurpose oxypyridones and their functional use | 英菲诺姆国际有限公司 | 2024-08-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240294840-A1 | MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 | SIGMAR1, OXGR1, OPRM1 | TYR 2437/4885COMT 2336/4885LMNA 4465/4885 |
| US-12606766-B2 | Multipurpose oxypyridinones and their functional use-4 | PHOSPHO1, SIGMAR1, SGMS1 | TYR 2120/4885COMT 4660/4885LMNA 2683/4885 |
| US-12606765-B2 | Multipurpose oxypyridinones and their functional use—1 | SIGMAR1, PHOSPHO1, SGMS1 | TYR 2652/4885COMT 4646/4885LMNA 1789/4885 |
| US-12503666-B2 | Multipurpose oxypyridinones and their functional use-2 | SIGMAR1, OXGR1, OPRM1 | TYR 2437/4885COMT 2336/4885LMNA 4465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.